Advancements in High-Purity Chemical Manufacturing and Expanding Industrial Applications to Drive Global Strontium Bromide Market to USD 412.60 Mn by 2033 at an 8.8% CAGR – Coherent Market Insights
The global strontium bromide market was valued at USD 228.75 Mn in 2026, according to Global Strontium bromide Market Report, by Type (Strontium Bromide Hexahydrate and Strontium Bromide Anhydrous), by Application (Analytical Reagents, Pharmaceuticals, Water Treatment and others (Flares, etc.)), and by Region (North America, Latin America, Asia Pacific, Europe, and Middle East & Africa), published by Coherent Market Insights.
The global strontium bromide market is expected to surpass USD 412.60 Mn by 2033, exhibiting a CAGR of 8.8% during the forecast period (2026-2033).
Strontium is a mineral found in seawater and soil. Strontium can be mainly obtained from seafood, but it can also be found in small amounts in whole milk, wheat bran, meat, poultry, and root vegetables. Strontium is similar to calcium. Strontium is quite common in nature, according to the Minerals Education Coalition (MEC) it is the 15th most abundant element in Earth's crust. Strontium occurs in about 0.03 percent of all igneous rock, according to the US Geological Survey (USGS). Bromine occurs in compounds present in sea water, natural brines and salt-lake evaporates. The strontium bromide or SrBr2 can be prepared from strontium hydroxide and hydrobromic acid. Alternatively, strontium carbonate can also be used as a strontium source. The strontium bromide is divided into 2 types, strontium bromide hexahydrate and strontium bromide anhydrous. The strontium bromide hexahydrate is an inorganic salts containing water molecules combined in a definite ratio as an integral part of the crystal which have crystallized the metal complex with strontium bromide. The strontium bromide hexahydrate is used as a pharmaceutical intermediate.
The pharmaceutical intermediate market is a blooming field in the production of drugs around the world. Leading biopharmaceutical and pharmaceutical manufacturing companies are focusing on improving their product footprint globally. These companies are focusing on strengthening their product reach in different countries across the world through various distribution channels. For instance, in July 2018, Pfizer, which is pharmaceutical company announced about the investment of around US$ 500 million to build a sterile injectable plant in Portage, Michigan. The heavy investments made by the pharmaceutical companies is driving the demand for pharmaceutical intermediate and it will also benefit the global strontium bromide market growth.
To know the latest trends and insights prevalent in this market, click the link below:
https://www.coherentmarketinsights.com/market-insight/strontium-bromide-market-5294